Cover Image

Comparison of measurement of serum tsh by two 3rd generation techniques.

Amandeep Kaur*, Minni Verma, Shalini Gupta, Vaneet Kaur, Brinder Chopra, Kamaljit Singh


The present study compared the measurement of serum TSH by two 3rd generation methods based on different principles i.e. Chemiluminesence (CLIA) and Fluorometric enzyme immuno-assay (FEIA). Main aim of the study was to evaluate the usefulness of the more sensitive assay method in patients with thyroid disease and non-thyroid illness (NTIs). Blood samples were withdrawn randomly from 125 subjects attending OPD and same sample was analyzed for TSH on two equipment’s based on methods with different principles.i.e. CLIA (Chemiluminesence) and FEIA (AIA-360). Out of 125 serum samples, the levels of TSH were within normal range in 68 subjects, were above normal range in 35 subjects and were below normal range in 22 subjects by both the methods. A specific value for TSH could not be reported by FEIA based equipment-AIA-360 in 14 (63.6%) out of total 22 hyperthyroid subjects taken up for the study.  The TSH values in 35 hypothyroid subjects obtained by two different method was also significantly (p< 0.0001) different. This clearly indicates that the Chemiluminesence assay system is far superior with respect to precision and sensitivity as compared to FEIA for reporting subnormal TSH levels as well as above normal TSH and can be useful in detection of SCTDs (subclinical thyroid dysfunction) and  in screening of thyroid diseases.


Third generation TSH assay; Chemiluminesence assay / FEIA method.

Full Text:



Fitzgerald PA. Endocrinology. In: Tierney LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis and treatment, 5th edition. The McGraw Hill Companies, United States of America 2006:1098-1193.

Lemon C. Title of subordinate document. In: what is third generation TSH? Available via http:// Updated on 13 jan, 2010.

Yalow RS and Berson SA. Immunoassay of endogenous plasma insulin in man. J Cln Invest; 1960; 39; 1157-1175.

Utiger RD. Radioimmunoassy of human plasma thyrortropin. Journal of Clinical Investigation; 1965; 44; 1277-1286.

Odell WD, Wilber JF and Paul E. Radioimmunoassy Of thyrortropin in human serum. Journal of Clinical Endocrinology.1965; 25; 1179-1188.

Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D and Nicoloff JT. Applications of a new chemiluninometric thyrotropin assay to subnormal measurement. Journal of clinical Endocrinol Metabolism.1990; 70; 453-460.

Evans M, Croxson MS, Wilson TM and Ibbertson HK. The screening of patients with suspected thyrotoxicosis using a sensitive TSH radioimmunoassay. Clinical Endocrinology.1985; 22; 445-451.

Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS and Nicol off JT. TRH stimulation test responses employing third and fourth generation TSH assays. Journal of Clincal Endocrinology Metabolism.1993; 76; 494-498.

Atmaca H, Tanriverdi F, Gokce C, Unluizarci K and Kelestimur F, Do we still need stimulation test? Thyroid.2007; 17; 529-533.

Duntas LH and Emerson CH, On the Fortieth Anniversary of Thyrotropin-Releasing Hormone: The Hormone that Launched a New Era. Thyroid .2009; 19; 1299-1301.

Seth J, Kellett HA, Caldwell G, Sweeting VM, Beckett GJ, Gow SM and Toft AD. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotropin releasing test. British Medical Journal.1984; 289; 1334-1336.

Roher F, Zedh C, Zimmermann MB and Hurrell RF, Journal of Clinical Laboratory Analysis 2005; 19(6): 196-98.

Spencer CA, Thyroid profiling for the 1990 s: Free T4 estimate or sensitive TSH measurement J Clin Immunoassay. 1989; 12; 82-89.

Hay ID, Klee GG, Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease. Clinical Chemistry.1993; 39; 1519-1524.

Spencer CA, Takeuchi M and Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clinical Chemistry.1996:42:1140-1145.

Ladenson PW, Singer PA and Ain KB American thyroid. Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573 – 1577.

Baskin HJ, Cobin RH, Duick DS, American association of clinical endocrinologists’ medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457- 469.

Science. gov. updated 2013.

Hubl W, Meissner D, Demant T, Becker W, Hörmann R, Bach M and Mack M. Evaluation of the LIAISON thyroid chemiluminescence immunoassays. Clin Lab. 2000; 46; 181-189.

Rawlins ML, Roberts WL, Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem 2004; 50; 2338-2344.

Waskiewicz D, Burkhardt A and Emancipator K. Performance Characterstic of 6 Third Generation Assays for Thyroid Stimulating Hormone. Clinical Chemistry.2005; 51; 1904-1905.



  • There are currently no refbacks.

Copyright (c) 2014 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.